Alacrita

John Brown, CBE, PhD, MBA, FRSE, has extensive experience in the life sciences sector. He is Chairman of BTG plc, Axis Shield plc and CXR Biosciences Ltd and a non-executive Director of Vectura Group plc, and was a Director of Cambridge Antibody Technology plc until its acquisition by AstraZeneca.

In the public sector he Chairs the Roslin Foundation and the Life Sciences Industry Advisory Board and is a non-executive director of the Technology Strategy Board. He is an advisor to several private equity and venture capital funds, a Fellow of the Royal Society of Edinburgh and Honorary Professor of the University of Edinburgh.

Until Dec 2003, John was Chief Executive of Acambis plc, a leading producer of vaccines to treat and prevent infectious disease. John holds an MBA and a PhD in neuropharmacology.